479 related articles for article (PubMed ID: 18502503)
61. Incidence of asparaginase-related hepatotoxicity, pancreatitis, and thrombotic events in adults with acute lymphoblastic leukemia treated with a pediatric-inspired regimen.
Christ TN; Stock W; Knoebel RW
J Oncol Pharm Pract; 2018 Jun; 24(4):299-308. PubMed ID: 28355969
[TBL] [Abstract][Full Text] [Related]
62. Turbid serum in a patient of acute lymphoblastic leukemia on treatment--what to look for?
Singh T; Satheesh CT; Madhumathi DS; Goyal M; Rajeev LK; Lakshmaiah KC; Suresh TM; Babu KG
J Cancer Res Ther; 2009; 5(3):219-20. PubMed ID: 19841569
[No Abstract] [Full Text] [Related]
63. A case report of an adult with severe hyperlipidemia during acute lymphocytic leukemia induction therapy successfully treated with plasmapheresis.
Nakagawa M; Kimura S; Fujimoto K; Atumi H; Imura J; Chikazawa Y; Imamura H; Okuyama H; Yamaya H; Fukushima T; Nakagawa A; Asaka M; Yokoyama H
Ther Apher Dial; 2008 Dec; 12(6):509-13. PubMed ID: 19140851
[TBL] [Abstract][Full Text] [Related]
64. [Effective combination chemotherapy with rituximab for acute lymphoblastic leukemia with bone relapse after bone marrow transplantation].
Abe T; Kitajima T; Honma K; Kurasaki T; Okazuka K; Shibasaki Y; Momoi A; Kuroha T; Masuko M; Yagisawa K; Furukawa T; Toba K; Aizawa Y
Rinsho Ketsueki; 2008 Nov; 49(11):1556-61. PubMed ID: 19047788
[TBL] [Abstract][Full Text] [Related]
65. Relationship between modified CT severity index and clinical features of L-asparaginase-associated pancreatitis in pediatric acute lymphoblastic leukemia.
Oh HJ; Im SA; Lee JW; Chung NG; Cho B
Pediatr Hematol Oncol; 2014 Oct; 31(7):647-55. PubMed ID: 24933500
[TBL] [Abstract][Full Text] [Related]
66. [Progress in researches on L-asparaginase targeted to childhood leukemia].
Cui YQ; Chen FX; Wu ZL
Zhonghua Er Ke Za Zhi; 2004 Mar; 42(3):227-30. PubMed ID: 15144726
[No Abstract] [Full Text] [Related]
67. Antithrombin supplementation III in childhood acute lymphoblastic leukemia treated with L-asparaginase.
Matsuzaki A; Suminoe A; Hara T
Pediatr Hematol Oncol; 2002 Dec; 19(8):601-3. PubMed ID: 12487838
[TBL] [Abstract][Full Text] [Related]
68. Asparaginase in the management of adult acute lymphoblastic leukaemia: is it used appropriately?
Patil S; Coutsouvelis J; Spencer A
Cancer Treat Rev; 2011 May; 37(3):202-7. PubMed ID: 20822851
[TBL] [Abstract][Full Text] [Related]
69. Thrombotic nephropathy and pulmonary hypertension following autologous bone marrow transplantation in a patient with acute lymphoblastic leukemia: case report.
Perkowska-Ptasinska A; Sulikowska-Rowinska A; Pazik J; Komuda-Leszek E; Durlik M
Transplant Proc; 2006; 38(1):295-6. PubMed ID: 16504729
[TBL] [Abstract][Full Text] [Related]
70. Managing hypersensitivity to asparaginase in pediatrics, adolescents, and young adults.
Shinnick SE; Browning ML; Koontz SE
J Pediatr Oncol Nurs; 2013; 30(2):63-77. PubMed ID: 23380527
[TBL] [Abstract][Full Text] [Related]
71. Catastrophic thromboembolism in a patient with acute lymphoblastic leukemia and hypereosinophilia.
Williams E; Smart SC; Go RS
Haematologica; 2004 Apr; 89(4):EIM01. PubMed ID: 15075104
[No Abstract] [Full Text] [Related]
72. Lymphocyte reconstitution after allogeneic bone marrow transplantation in a previously thymectomized patient--no evidence of extrathymic T-cell maturation.
Giebel S; Dziaczkowska J; Wysoczanska B; Wojnar J; Krawczyk-Kulis M; Lange A; Holowiecki J
Bone Marrow Transplant; 2007 Oct; 40(7):705-6. PubMed ID: 17680024
[No Abstract] [Full Text] [Related]
73. Eligibility for allogeneic transplantation in very high risk childhood acute lymphoblastic leukemia: the impact of the waiting time.
Balduzzi A; De Lorenzo P; Schrauder A; Conter V; Uderzo C; Peters C; Klingebiel T; Stary J; Felice MS; Magyarosy E; Schrappe M; Dini G; Gadner H; Valsecchi MG
Haematologica; 2008 Jun; 93(6):925-9. PubMed ID: 18413892
[TBL] [Abstract][Full Text] [Related]
74. [Distal coronary thrombosis during L-asparaginase treatment for an acute lymphoblastic leukaemia].
Fraison JB; Calvet P; Domnisoru I; Altamiranda S; Vernhet-Kovacsik H; Saad A; Gallay P; Reny JL; Berdague P
Ann Cardiol Angeiol (Paris); 2012 Aug; 61(4):303-5. PubMed ID: 21663890
[TBL] [Abstract][Full Text] [Related]
75. A genome-wide view of the in vitro response to l-asparaginase in acute lymphoblastic leukemia.
Fine BM; Kaspers GJ; Ho M; Loonen AH; Boxer LM
Cancer Res; 2005 Jan; 65(1):291-9. PubMed ID: 15665306
[TBL] [Abstract][Full Text] [Related]
76. Is asparaginase a critical component in the treatment of acute lymphoblastic leukemia?
Douer D
Best Pract Res Clin Haematol; 2008 Dec; 21(4):647-58. PubMed ID: 19041604
[TBL] [Abstract][Full Text] [Related]
77. A fluorometric assay for L-asparaginase activity and monitoring of L-asparaginase therapy.
Ylikangas P; Mononen I
Anal Biochem; 2000 Apr; 280(1):42-5. PubMed ID: 10805519
[TBL] [Abstract][Full Text] [Related]
78. Acute haemorrhagic pancreatitis following L-asparaginase therapy in acute lymphoblastic leukaemia --a case report.
Tan CL; Chiang SP; Wee KP
Singapore Med J; 1974 Dec; 15(4):278-82. PubMed ID: 4533158
[No Abstract] [Full Text] [Related]
79. L-Asparagine depletion levels and L-asparaginase activity in plasma of children with acute lymphoblastic leukemia under asparaginase treatment.
Tsurusawa M; Chin M; Iwai A; Nomura K; Maeba H; Taga T; Higa T; Kuno T; Hori T; Muto A; Yamagata M;
Cancer Chemother Pharmacol; 2004 Mar; 53(3):204-8. PubMed ID: 14634792
[TBL] [Abstract][Full Text] [Related]
80. Asparaginase-associated pancreatitis in childhood acute lymphoblastic leukaemia: an observational Ponte di Legno Toxicity Working Group study.
Wolthers BO; Frandsen TL; Baruchel A; Attarbaschi A; Barzilai S; Colombini A; Escherich G; Grell K; Inaba H; Kovacs G; Liang DC; Mateos M; Mondelaers V; Möricke A; Ociepa T; Samarasinghe S; Silverman LB; van der Sluis IM; Stanulla M; Vrooman LM; Yano M; Zapotocka E; Schmiegelow K;
Lancet Oncol; 2017 Sep; 18(9):1238-1248. PubMed ID: 28736188
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]